Free certificates of participation are available upon successful completion of a brief knowledge quiz at: https://www.classmarker.com/online-test/start/?quiz=bj458d0a4e948a9e
For more than 20 years, researchers have been studying TMS as a potential therapy for a number of neurological and psychiatric conditions. Join Dr. Lindsay Oberman, Co-Investigator & Associate Director of Clinical Research of the Rhode Island Consortium for Autism Research and Treatment (RI-CART) for this presentation on the latest research findings and updates.
The YouTube video shared during the presentation is online at: https://www.youtube.com/watch?v=qkNbYHu_STU
Lindsay Oberman received her PhD in experimental psychology at University of California, San Diego in 2007. While in graduate school she used electroencephalography (EEG) and electromyography (EMG) to study the brain basis of social impairments in children with autism spectrum disorders. Oberman then obtained a mentored postdoctoral fellowship at the Berenson-Allen Center for Noninvasive Brain Stimulation at Harvard Medical School where she developed paradigms using transcranial magnetic stimulation (TMS) to study brain plasticity and excitability in individuals with autism spectrum disorders. Oberman was an Instructor in the department of neurology at Harvard Medical School with appointments both at Beth Israel Deaconess Medical Center and Children’s Hospital, Boston prior to coming to Bradley Hospital. Oberman's research focuses on autism spectrum disorders. Autism is a pervasive developmental disorder characterized by a number of impairments including a lack of social empathy, a lack of understanding of others' thoughts and facial expressions, a delayed or complete absence of communication skills, difficulty with imagination, and difficulty with social interaction. Though many theories exist on the neurological basis of this enigmatic disorder, the exact cause is largely unknown. Oberman's research interest lies in using electrophysiological techniques (such as EEG and TMS and TCS) to investigate neural circuits whose dysfunction may account for the behavioral pathology seen in autism spectrum disorders with the long term goal of developing novel therapeutic interventions.